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Fadi G. Hage, MD,yz Ami E. Iskandrian, MDySEE PAGE 553T he latest data from the United States RenalData System indicate that 17,305 renal trans-plants were performed in the United States in
2012, the majority from deceased donors (1). At the
end of 2012, there were 81,981 candidates listed on
the transplant list. Although a proportion of these
had an inactive status on the waiting list, the imbal-
ance between the availability of organs and the num-
ber of candidates clearly poses a challenge for
allocating organs; the result is a median wait time to
transplantation of 3.6 years. While the kidney trans-
plant list has been growing over the years, the num-
ber of kidney transplants performed in the United
States has been relatively stable since 2005, indi-
cating that the relative paucity of organs is expected
to intensify going forward. Cardiovascular disease
is the leading cause of morbidity and mortality
in patients with end-stage renal disease pre-
transplantation, the leading cause of death in the
peri-transplant period, and a major cause of loss of
functioning allografts at 10 years after transplanta-
tion (2–4). Thus, there is a general consensus on the
need for pre-transplant cardiovascular evaluation
and risk stratiﬁcation, although the best strategy to
achieve this goal has been controversial.
The 2012 scientiﬁc statement from the American
Heart Association and the American College of
Cardiology Foundation on Cardiac Disease Evalua-
tion and Management Among Kidney and Liver
Transplantation Candidates was endorsed by the
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tional Kidney Foundation. The statement recom-
mends that noninvasive stress testing may be
considered in kidney transplantation candidates with
no active cardiac conditions based on the presence of
multiple coronary artery disease (CAD) risk factors
regardless of functional status (Class IIb, Level of
Evidence: C) (5). Routine invasive coronary angiog-
raphy in all patients being considered for trans-
plantation is unlikely to be justiﬁed due to the
associated risk of the procedure and the inconsis-
tency of the prognostic data derived from angiog-
raphy (6). In the absence of solid data for or against
screening for myocardial ischemia, transplant centers
have varied in their implementation of screening
protocols but have generally relied on noninvasive
stress testing in a variable proportion of patients
listed for possible transplantation (based on age
and number of risk factors) to assist in risk stratiﬁ-
cation (7).In this issue of iJACC, Winther et al. (8) report on a
prospective study of 138 patients referred for pre–
renal transplant cardiac evaluation who underwent
routine imaging with computed tomography for
Agatston coronary artery calcium scoring (CACS) and
coronary computed tomography angiography (CTA),
stress myocardial perfusion imaging (MPI) with gated
single-photon emission computed tomography, and
invasive coronary angiography (ICA). The aim of the
study was to identify the accuracy of these noninva-
sive tests for the diagnosis of obstructive CAD by
using ICA. With ICA, 22% had obstructive CAD (>70%
luminal area reduction or 50% diameter reduction),
the majority of which were 1-vessel disease (73%);
17% had 2-vessel disease, and 10% had 3-vessel or left
main disease.
The sensitivity and speciﬁcity for obstructive CAD
were 67% and 77% for CACS (>400), 93% and 63% for
coronary CTA (nonevaluable segments were deﬁned
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564as having obstructive CAD), and 53% and 82% for MPI
(summed difference score $4, a reduction of left
ventricular ejection fraction >10% during stress,
transient ischemic dilation, and left ventricular ejec-
tion fraction <45% in patients without prior coronary
revascularization) (8). The authors concluded that
coronary CTA had a higher sensitivity but a lower
speciﬁcity for diagnosing obstructive CAD than CACS
or MPI. When the data for coronary CTA and MPI were
combined, the sensitivity decreased (67%) and the
speciﬁcity increased (86%) compared with coronary
CTA alone. However, these numbers were not statis-
tically different from those obtained by MPI alone.
These results (8) are interesting and provide
important data regarding the diagnostic capabilities
of the different noninvasive imaging modalities in
this patient population. The study design was
appropriate to avoid referral bias, the readers were
blinded to the results of the other imaging modalities
(including ICA), and it is notable that only 29 patients
were excluded because they did not undergo imaging
with all modalities. Some factors that may have
altered the performance of MPI include the use of a
nonconventional cutoff for the summed difference
score and the inclusion of nonperfusion abnormal-
ities, which are not universally accepted as predictors
of CAD in the presence of normal perfusion on im-
aging. Furthermore, imaging in patients with chronic
kidney disease poses special challenges related to
artifacts that are particular to this population (2). For
coronary CTA, considering nonevaluable segments to
have obstructive CAD may have artiﬁcially inﬂated
the sensitivity and deﬂated the speciﬁcity of this
modality because it affected 25 patients (18%). The
inﬂuence of nonevaluable segments is of clinical
concern because it may lead to downstream testing
with a different modality in 1 of every 5 patients. The
authors tried to account for the nonevaluable seg-
ments by combining the data from coronary CTA and
MPI, but this approach resulted in unconventional
deﬁnitions that are not applicable in practice (e.g., a
patient with 2-vessel CAD by coronary CTA and
normal perfusion by MPI was labeled as normal) and
the obvious implication of the need for dual imaging
in every patient.
An important consideration in the diagnostic per-
formance of MPI is the lack of concordance between
myocardial ischemia and obstructive CAD, a conceptthat has been rediscovered in light of fractional ﬂow
reserve data (9). One can argue that a 70% luminal
area stenosis by ICA is not the proper gold standard
for assessment of myocardial ischemia because many
patients meeting this criterion do not have ischemia,
and myocardial ischemia can be present with less
severe obstruction. The real question yet to be
addressed is not whether these patients have
obstructive CAD on angiography but rather whether
they are at high cardiovascular risk in the near-term
and the long-term. As alluded to earlier, studies
have shown that MPI may carry more prognostic in-
formation than ICA in this population (10,11) and has
been associated with cardiac outcomes after trans-
plantation (12,13). In this regard, it has been observed
that the majority of deaths in patients with end-stage
renal disease are related to sudden cardiac deaths
rather than myocardial infarction. This ﬁnding sug-
gests that assessment of left ventricular function and
other novel predictors of sudden death may add
prognostic data to the assessment of myocardial
ischemia and CAD (2,14).
When implementing a screening protocol in an
asymptomatic cohort, we must be cautious with
respect to the risk–beneﬁt ratio so that we do not
inadvertently produce net harm to the patients.
Contrast-induced nephropathy associated with cor-
onary CTA and ICA is of particular concern if
screening is to be performed before initiation of
dialysis. In the described cohort, 15% of patients
were started on dialysis after coronary CTA and
within 30 days of ICA. Finally, it may be prudent to
use imaging in a subset of patients at clinically high
risk of events rather than in the entire population if
the purpose is to identify patients with 3-vessel CAD
(only 2% in this cohort). The scientiﬁc statement
from the American Heart Association (5) provides a
starting point. Further research is needed, however,
to determine who will beneﬁt from imaging during
evaluation before renal transplantation and how to
intervene to decrease risk in response to imaging
ﬁndings (7).
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